Type to search…

Triple-agonist peptide (GLP-1/GIP/glucagon) for metabolic and body-composition research. Supplied as lyophilized powder in 5 mg and 10 mg vials.
Retatrutide is a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors for metabolic and body-composition research. It is supplied as lyophilized powder in 5 mg and 10 mg vials for controlled laboratory reconstitution and dose-preparation workflows.